Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00891228 · ClinicalTrials.gov registry record · Phase 1
Study of the Safety, and Sperm and Gonadotropin Suppression of a Contraceptive Gel in Normal Men
A Phase 1 study, sponsored by Premier Research.
- Completed
- Registry status
- Phase 1
- Development phase
- 99
- Enrollment target
NCT00891228 is a Phase 1 study that has completed, run by Premier Research. The registered enrollment target is 99 participants.
The verdict
NCT00891228, a Phase 1 study, has completed, sponsored by Premier Research.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 99 participants
- Enrollment target
Study Summary
To determine the number of men who have suppression of sperm production when using a daily regimen of Nestorone® Gel (0, 8 or 12 mg) and Testosterone Gel applied transdermally.
Interventions
- DRUG Testosterone
- DRUG Nestorone®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2009-05 |
| Est. Completion | 2011-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00891228
The ClinicalTrials.gov registry entry for NCT00891228 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Premier Research, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Testosterone is the first listed.
NCT00891228 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00891228 about?
NCT00891228 is a clinical study titled "Study of the Safety, and Sperm and Gonadotropin Suppression of a Contraceptive Gel in Normal Men". To determine the number of men who have suppression of sperm production when using a daily regimen of Nestorone® Gel (0, 8 or 12 mg) and Testosterone Gel applied transdermally.
What is the current status of trial NCT00891228?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 99 participants. The study started on 2009-05. Estimated completion is 2011-11.
What interventions are being tested in trial NCT00891228?
The interventions under investigation include: Testosterone (DRUG), Nestorone® (DRUG).
Who is sponsoring clinical trial NCT00891228?
This trial is sponsored by Premier Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.